Access Fertility
Access Fertility is a UK-based fertility-finance company that sells fixed-price IVF treatment programmes with up to 100% refunds if treatment fails, distributed through a 100+ partner clinic network across the UK, Ireland, and mainland Europe.
- Company typePrivate
- Founded2015
- HeadquartersHigham Ferrers, United Kingdom
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Access Fertility does
Access Fertility is a UK-based, privately held fertility-finance and program-management company founded in 2015 and headquartered in Higham Ferrers, Northamptonshire. It builds and distributes fixed-price IVF treatment programmes that bundle multiple egg collections with unlimited frozen embryo transfers, and underwrites a refund mechanism that returns up to 100% of the program fee if treatment does not result in a live birth. Its product portfolio comprises four tiers (Refund, Multi-Cycle, Unlimited, and Donor Egg), priced from approximately £7,250 to €19,000, plus a 0% interest finance product offered through its wholly-owned subsidiary Fertility Finance Ltd (company number 10508524), allowing patients to borrow up to £12,000 over 12 months.
The company's core technology is the Aphrodite Patient Portal for digital enrollment, form signing, and treatment tracking, supplemented by an online partner-clinic management system and the proprietary Fertility Calculator and IVF Cost Calculator tools. Payments are processed via TrueLayer under open banking, and the company integrates with Google Analytics for web analytics. No public API or partner-facing developer platform exists; the technology layer is functional rather than technically differentiated.
Access Fertility distributes its programmes through a hybrid go-to-market combining direct-to-consumer acquisition (website, phone-based Patient Advisors, free nurse consultations, content marketing) with a network of 100+ partner fertility clinics across the UK, Ireland, Spain, Portugal, Poland, and Greece that administer treatments and refer patients. Revenue is generated from upfront programme fees (retained on successful outcomes, partially refunded on unsuccessful ones) and from finance arrangements, with the refund mechanism functioning economically as an insurance pool across participants. The company is led by founder and CEO Ash Carroll-Miller, with a senior team including a COO, Medical Director (Professor Scott Nelson of the University of Glasgow), CTO, General Counsel, Head of Commercial, Senior Underwriter, and country managers, and is privately held with no external institutional investment evidenced in the available materials.
Access Fertility firmographics
Firmographics- Name
- Access Fertility
- Legal name
- ACCESS FERTILITY LIMITED
- Website
- https://accessfertility.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Access Fertility is a UK-based fertility-finance company that sells fixed-price IVF treatment programmes with up to 100% refunds if treatment fails, distributed through a 100+ partner clinic network across the UK, Ireland, and mainland Europe.
- Ownership category
- akta.pro rank
Where Access Fertility is headquartered
LocationHeadquarters
- HQ city
- Higham Ferrers
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Access Fertility business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- IVF Program Fees: Access Fertility generates revenue by charging fixed fees for multi-cycle IVF treatment packages. Patients pay upfront for programs (Refund, Multi-Cycle, Unlimited, Donor Egg) that bundle multiple IVF cycles at discounted rates compared to pay-as-you-go clinic pricing. The company retains revenue from successful treatments while refunding unsuccessful ones.
- 0% Interest Finance: Finance solutions for patients to spread the cost of treatment. FERTILITY FINANCE LTD (company number 10508524) provides lending services. While marketed as 0% interest, the company generates revenue through these financial arrangements.
- Refunds as Insurance Mechanism: The refund programs function as an insurance mechanism. Patients who don't achieve a live birth receive refunds (50%, 70%, or 100%), while successful patients' fees are retained by the company. This creates a risk pool across all program participants.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | IVF Refund Programme - 100% refund option |
| Subscription | Pay-as-you-go | IVF Refund Programme - 70% refund option |
| Subscription | Pay-as-you-go | IVF Refund Programme - 50% refund option |
| Subscription | Pay-as-you-go | IVF Multi-Cycle Programme |
| Subscription | Pay-as-you-go | IVF Unlimited Programme |
| Subscription | Pay-as-you-go | Donor Egg Refund Programme |
| Subscription | Monthly | 0% Interest Finance |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels9 records
Access Fertility product offering
Product offeringCore offering
Access Fertility sells fixed-price, multi-cycle IVF treatment programmes that bundle multiple egg collections and unlimited frozen embryo transfers, with refund protection of up to 100% if treatment does not result in a live baby. It also offers a 0% interest finance product to spread treatment costs and operates the Aphrodite patient portal for digital enrollment and treatment tracking across its UK, Ireland, and European partner clinic network.
Product overview
Access Fertility offers a portfolio of four refund-based IVF treatment programmes designed to reduce financial risk and costs for patients undergoing fertility treatment. The core portfolio consists of: the IVF Refund Programme (2-3 cycles with up to 100% refund if no baby, for patients under 40), the Multi-Cycle Programme (2 cycles at discounted price for patients under 45), the Donor Egg Refund Programme (for patients under 49 using donor eggs with 50-100% refund options), and the Unlimited Programme (unlimited cycles over 2 years with 100% refund for patients under 38). These programmes are supplemented by a 0% Interest Finance option (borrow up to £12,000 over 12 months), free patient tools including a Fertility Calculator and IVF Cost Calculator, and the Aphrodite Patient Portal for digital enrollment and treatment tracking. All programmes include unlimited frozen embryo transfers, in-cycle bloods and scans, blastocyst culture and transfer, and access to partner clinics across the UK, Ireland, and Europe.
Differentiator
Problem solved
Functional benefit
Brands
- Aphrodite: Patient portal used to enrol patients onto programmes and track treatment.
- IVF Refund Programme
- Multi-Cycle Programme
- Donor Egg Programme
- Unlimited Programme
Products and services
- IVF Refund Programme Multiple IVF cycles (2 or 3 egg collections with unlimited frozen embryo transfers) for a fixed price with up to 100% refund if treatment does not result in a baby. Available to patients under 40 using their own eggs, subject to medical review with a 90% acceptance rate.
- IVF Multi-Cycle Programme Multiple cycles of IVF for a fixed, discounted price (up to 30% savings vs paying clinic directly) with 2 egg collections and unlimited frozen embryo transfers. Available to patients under 45 with a 100% acceptance rate and no medical review required.
- Donor Egg Refund Programme
Quantifiable outcome
- Over 12,000 babies born through Access Fertility programs
- +5 more outcomes
Companies that use Access Fertility
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Access Fertility technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature4 records
Access Fertility partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, flagship and minor.
- SIMS IVF Clinics (Ireland Network)coreSIMS IVF is a major fertility clinic network in Ireland with locations in Dublin (Clonskeagh), Cork, Limerick, Dundalk, Swords, and Carlow satellite clinic. They provide IVF/ICSI treatment services to Access Fertility program patients. Egg collections and embryo transfers at main clinics; satellite clinics provide bloods and scanning services.
- ReproMed IrelandcoreReproMed is a fertility clinic network in Ireland with locations in Dublin, Cork, Galway, Kilkenny, and Swords satellite clinic. They provide IVF/ICSI treatment services to Access Fertility program patients.
- UK Fertility Clinics NetworkcoreAccess Fertility partners with approximately 70 clinic sites across the UK offering IVF/ICSI treatment programs. Specific named UK partners include Manchester Fertility (where the first money-back guarantee was piloted), TFP Nurture Fertility Clinic, London Women's Clinic (Wales), Lister Fertility Clinic, Hull & East Riding Fertility, and LCRH.
- European Fertility ClinicscorePartner clinics in Spain, Portugal, Poland, and Greece serving European patients. Portugal-specific contact number +351 308 815 000. Programs available in multiple European languages.
- Manchester FertilityflagshipFirst UK clinic to pilot Access Fertility's money-back guarantee program in 2014. Embryologists at Manchester Fertility were the first in Britain to offer the 'money back guarantee' concept for IVF treatment.
- Bourn Hall CliniccorePartner clinic working with BICA (British Infertility Counselling Association) on patient experience research. Access Fertility supports infertility counselling initiatives.
- HFEA (Human Fertilisation and Embryology Authority)minorUK independent regulator overseeing use of gametes and embryos in fertility treatment. Access Fertility refers patients to check clinic success rates on HFEA website.
- IVF BabbleminorFertility information website with patient stories featured on Access Fertility blog. Provides accessible fertility information explained in digestible format.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Access Fertility competitors and assessment
Company assessmentDirect peers
- ARC Fertility: ARC Fertility is the closest US analog to Access Fertility, offering IVF refund, multi-cycle, and financing programs to patients across the US through partner clinics. Same core product (multi-cycle bundles with refund protection) and same intermediary business model.
- Future Family: US fertility financing and care-navigation company offering loans and packaged IVF plans. Directly comparable in providing patient-facing financing and multi-cycle packages, though focused on the US rather than Europe.
- WIN Fertility: US fertility benefits and financing provider offering refund/assurance-style programs through employer benefit plans. Closely comparable to Access Fertility's insurance-like refund product architecture.
Broad incumbents
- Kindbody: US fertility clinic operator and benefits provider with its own clinics plus employer fertility benefits. Comparable in the fertility access/affordability theme but with vertically integrated clinics, which is the disintermediation risk for Access Fertility.
- Progyny: US fertility benefits management platform that bundles IVF coverage for employer-sponsored plans. Comparable in addressing financial friction in IVF access, but operates via employer-sponsored benefits rather than direct-to-consumer refunds.
- Carrot Fertility: Global fertility benefits platform serving employers with inclusive fertility, family-forming, and hormonal-health benefits. Comparable in tackling the affordability and risk layer of fertility treatment, but with a B2B benefits structure rather than Access Fertility's D2C refund model.
Emerging players
- Maven Clinic: Virtual women's and family health platform covering fertility, pregnancy, and postpartum care. Comparable in addressing the financial and clinical-journey barriers around fertility, though primarily digital rather than a refund/insurance model.
Regional players
- Hertility Health: UK-based reproductive health testing and clinical pathway company focused on fertility assessment and at-home hormone testing. Comparable in offering UK patients a structured pathway into fertility services, though focused on diagnostics rather than refund financing.
- Gaia (Fertility): Portugal-based fertility clinic and reproductive medicine operator, comparable to Access Fertility's European clinic partnerships (Portugal in particular). Represents both a potential partner and a potential vertically-integrated competitor in the Iberian market.
Others
- Univfy: Provider of personalized IVF success-prediction models used by clinics and patients to forecast live-birth outcomes. Comparable in that Access Fertility's Fertility Calculator is built on similar multi-cycle cumulative success-rate methodology.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Access Fertility social profiles
Digital presenceAccess Fertility financial estimates
Financial estimateRevenue estimate
Valuation estimate
Access Fertility leadership team
Management profileNumber of profiles
Profiles7 records
Access Fertility subsidiaries and ownership
Company hierarchySubsidiaries4 records
Access Fertility funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Access Fertility M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Access Fertility
What does Access Fertility do?
Access Fertility sells fixed-price, multi-cycle IVF treatment programmes that bundle multiple egg collections and unlimited frozen embryo transfers, with refund protection of up to 100% if treatment does not result in a live baby. It also offers a 0% interest finance product to spread treatment costs and operates the Aphrodite patient portal for digital enrollment and treatment tracking across its UK, Ireland, and European partner clinic network.
Is Access Fertility a public or private company?
Access Fertility is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Access Fertility founded?
Access Fertility was founded in 2015. It employs 11 to 50 people.
Where is Access Fertility based?
Access Fertility is headquartered in Higham Ferrers, United Kingdom, in the Europe region.
How does Access Fertility make money?
Three revenue lines are on record. IVF Program Fees are the primary driver. The others are 0% Interest Finance and refunds as Insurance Mechanism.
Who are Access Fertility's main competitors?
Direct peers on record are ARC Fertility, Future Family and WIN Fertility. Broad incumbents are Kindbody, Progyny and Carrot Fertility. Maven Clinic is listed as an emerging player. Regional players are Hertility Health and Gaia (Fertility). Univfy is listed as an others.
Does Access Fertility have an API?
No public API is recorded for Access Fertility.